NEOGENOMICS INC — Director's Dealing 2024

Aug 13, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2024-08-10

Reporting Person: Kelly Michael Aaron (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-08-10	Common Stock	M	11336	—	Acquired	31755	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-08-10	Restricted Stock Unit	$0	M	11336	Disposed		Common Stock (11336)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$37.53	2027-05-28	Common Stock (2223)	2223	Direct
Stock Option (Right to Buy)	$40.90	2028-06-02	Common Stock (3714)	3714	Direct
Stock Option (Right to Buy)	$8.10	2029-06-10	Common Stock (13882)	13882	Direct
Stock Option (Right to Buy)	$14.82	2033-08-10	Common Stock (8353)	8353	Direct
Stock Option (Right to Buy)	$13.71	2034-06-01	Common Stock (8672)	8672	Direct
Restricted Stock Unit	$0		Common Stock (12254)	12254	Direct

Footnotes

F1: Reflects release of restricted stock units that were previously reported on a Form 4.

F2: Once vested, the shares of common stock are not subject to expiration.